• News
  • Sport
  • TV
  • Radio
  • Education
  • TV Licences
  • Contact Us
No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • SCI-TECH
  • LIFESTYLE
  • FEATURES
  • OPINION
Home Sci-tech

EMA committee recommends restrictions on fluoroquinolone, quinolone antibiotics

5 October 2018, 5:03 PM  |
Reuters Reuters |  @SABCNews

Image: SABC News AFP

The European Medicines Agency’s risk assessment committee has recommended restrictions on the use of broad-spectrum antibiotics fluoroquinolone and quinolone following a review of side effects, the EMA said on Friday.

The side effects were reported to be “disabling and potentially long-lasting”, though very rare, the EMA said.

These side effects mainly involved muscles, tendons and bones and the nervous system, it added.

The Pharmacovigilance Risk Assessment Committee (PRAC) said the antibiotics should only be used to treat infections when an antibiotic is essential and others cannot be used.

The PRAC recommended that some medicines, including all those that contain a quinolone antibiotic, should be removed from the market.

The U.S. Food and Drug Administration in July called for the safety labelling changes for fluoroquinolones to warn strongly about side effects including risks to mental health and serious blood sugar disturbances.

In 2016, the FDA had issued warnings about the association of fluoroquinolones with “disabling and potentially permanent side effects”.

The PRAC also repeated its precautionary advice on the use of GlaxoSmithKline’s HIV drug dolutegravir in pregnant women and women who can become pregnant.

U.S. and European regulators were assessing whether the drug might be linked to serious birth defects, casting a shadow over a medicine that has been a key profit driver in recent years.

Dolutegravir is a so-called integrase inhibitor found in the branded medicines Tivicay and Triumeq, which are sold by Healthcare unit.

Gilead Sciences makes a rival product called bictegravir.

The PRAC’s recommendations would now be sent to EMA’s Committee for Medicinal Products for Human Use (CHMP). While final approvals are up to the European Commission, it generally follows recommendations from the CHMP and endorses them within a couple of months.

Share article
Tags: RestrictionsAntibioticsEMAfluoroquinoloneEuropean Medicines AgencyQuinoloneSide effects
Previous Post

MTN receives counterclaim from Nigeria’s central bank – MTN lawyer

Next Post

ANC Gauteng threatens mass action amid demands

Related Posts

A boy plays with water on a hot summer day.

Toddlers, pregnant women vulnerable to death due to heatwave: SAMRC

27 January 2023, 11:17 AM

LIVE: 3D Construction Printing Housing Project launch

27 January 2023, 11:00 AM
3D construction printing technology.

3D technology project aims to modernise construction industry: DSI

27 January 2023, 10:20 AM
3D construction printing technology.

SA’s first 3D construction printing technology to be unveiled

27 January 2023, 7:15 AM
The CSIR works with government and industry to improve cybersecurity in the country

Cyber fraud remains biggest barrier to online shopping

26 January 2023, 8:15 PM
FILE PHOTO: Ten pills of the antibiotic "Amoxicillin

EU drug regulator decides ongoing antibiotic shortage not a ‘major event’

26 January 2023, 4:57 PM
Next Post
Thousands of ANC members marched through the city centre where they handed over memoranda to the offices of Johannesburg Mayor.

ANC Gauteng threatens mass action amid demands

Most Viewed

  • 24hrs
  • Week
  • Month
  • Parts of the Northern Cape to be exempted from rolling blackouts
  • Remedial programme reinstated to fight Hyacinth plants at Hartbeespoort Dam
  • Northern Cape’s Kakamas to be exempted from blackouts
  • Zuma joins AmaZulu King in commemorating the Battle of Isandlwana
  • Scorcher predicted in Northern Cape for two weeks
  • Parts of the Northern Cape to be exempted from rolling blackouts
  • VIDEO | St Benedict College’s Matric learner gets 11 distinctions
  • Limpopo matriculant from child-headed household attains diploma pass
  • Female circumcision practice thriving in Eastern Cape
  • Babes Wodumo breaks her silence at Mampintsha’s funeral
  • AG’s report points to billions of irregular expenditure in City of Tshwane
  • VIDEO | Repo rate increases by 25 basis points to 7.25%
  • Joburg Mayor Mpho Phalatse voted out of office
  • Diepsloot residents block N14 highway
  • Phalatse refuses to comment on DA’s sabotage allegations

LATEST

  • Business

LIVE: Media engagement with US Secretary of Treasury Janet Yellen


[File image]: Zandile Mafe, suspect accused of breaking into Parliament when the fire started, appears in the Cape Town Magistrates' Court.
  • South Africa

Mafe snubs pre-trial proceedings again, case postponed


A boy plays with water on a hot summer day.
  • Sci-tech

Toddlers, pregnant women vulnerable to death due to heatwave: SAMRC


  • Sci-tech

LIVE: 3D Construction Printing Housing Project launch


  • Politics

LIVE: City of Joburg Council elects new mayor


A man gets his finger inked before casting his vote at a polling station.
  • Politics

Al Jamah’s Thapelo Amad touted to be Joburg’s new mayor


Weather

  • About the SABC
  • Contact Us
  • Jobs
  • Advertise
  • Disclaimer
  • Site Map

SABC © 2022

No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • SCI-TECH
  • LIFESTYLE
  • FEATURES
  • OPINION

© 2022

Previous MTN MTN receives counterclaim from Nigeria’s central bank – MTN lawyer
Next ANC Gauteng threatens mass action amid demands